Investigator
Chief · National Hospital Organization Shikoku Cancer Center, Gastrointestinal Medical Oncology
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors
Chief
National Hospital Organization Shikoku Cancer Center · Gastrointestinal Medical Oncology
JP